Research Summary

The net interest margin will stay around the current levels. ROA also to stay around the current level that is…

“In FY24, Company’s profitability is expected to improve, driven by growth in Radiopharmaceuticals, Allergy Immunotherapy and CDMO Sterile Injectables businesses.…

“The distributor business has grown 50% in this period, which we are talking about from Q1 to Q3. Panel builders…

“I am delighted to report that for the second consecutive quarter, we have had record-breaking numbers with the highest-ever revenues…

“The company is looking for close to Rs. 500 Cr to Rs. 550 Cr of capex by March 2025 mainly…

“The revenues for Q3 of FY '23 stood at Rs. 792 crores, a decent 23% growth YoY. EBITDA margin stood…

“Our primary focus during Q3FY23 was to stabilize our business, have growth and profitability back on track, and achieve guided…

"Aarvi Encon's future growth strategy includes increasing the wallet share of business from existing clients by supplying additional manpower and…

“As per RBI's estimate, the next year inflation is expected to further moderate to around 5.3%, combined with a fairly…

I believe India is well placed in the post pandemic world. Our favorable demographics, stable democratic set up, and increasing…